This spring allergy season, if you suffer from the distraction and annoyance of itchy eyes or nose, imagine that intense itch across your entire body

The transformation of MPNs to blast-phase (BP) is generally associated with poorer long-term survival. A recently published study in Blood Advances looked at outcomes of

Profile: Belinda Guo, PhD, University of Western Australia One of the impacts MPN research Foundation (MPNRF) has on the global MPN community is the support

Today, it is essential for patients to be involved with research and drug developers as they progress through the various stages of bringing a new

Several studies have confirmed the association of ruxolitinib (a JAK inhibitor) with increased risk of non-melanoma skin cancers (NMSCs). A study published in a January

  Jyoti Nangalia, MBBS, PhDWellcome Sanger Institute It is known that JAK2 mutations are found in “healthy” people around the world, particularly in older individuals.